Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Increasing evidence suggests the bidirectional interplay between parathyroid hormone and aldosterone as an important mechanism behind the increased risk of cardiovascular damage and bone disease observed in primary hyperparathyroidism. Our primary object is to assess the efficacy of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomaschitz, Andreas, Fahrleitner-Pammer, Astrid, Pieske, Burkert, Verheyen, Nicolas, Amrein, Karin, Ritz, Eberhard, Kienreich, Katharina, Horina, Jörg H, Schmidt, Albrecht, Kraigher-Krainer, Elisabeth, Colantonio, Caterina, Meinitzer, Andreas, Pilz, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515510/
https://www.ncbi.nlm.nih.gov/pubmed/22974443
http://dx.doi.org/10.1186/1472-6823-12-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515510/
https://www.ncbi.nlm.nih.gov/pubmed/22974443
http://dx.doi.org/10.1186/1472-6823-12-19

Ejemplares similares